Molson Coors Beverage Co (TAP) · Nov 5, 2026 · Earnings
In line — Underlying EPS $1.46 vs ~$1.47 consensus; net sales $2.93B vs ~$2.94B
Molson Coors earnings were roughly in line on EPS, but falling beer volumes, inflation and weaker underlying profit cloud the Horizon 2030 turnaround.
Molson Coors is early in its Horizon 2030 reset: it is trying to rebuild brand momentum, expand beyond traditional beer, and simplify costs while managing a soft beer market. Its prior-quarter baseline was already weak—Q2 sales declined and full-year guidance was reaffirmed—so this quarter was mainly a test of whether pricing and restructuring could offset volume pressure.
| Metric | Q3 2026 | Q3 2025 | Consensus / comparator |
|---|---|---|---|
| Net sales (Consolidated performance) | $2,926.5M (-1.6%) | $2,973.5M | ~$2,940M |
| Underlying diluted EPS (Consolidated performance) | $1.46 (-12.6%) | $1.67 | ~$1.47 |
| Financial volume (Worldwide and segment volume) | 18.809M hl (-3.0%) | 19.385M hl | — |
| Brand volume (Worldwide and segment volume) | 19.376M hl (-4.9%) | 20.366M hl | — |
| Underlying free cash flow, YTD (Free cash flow reconciliation) | $852.0M | $782.1M | — |
| Net debt / underlying EBITDA (Net debt reconciliation) | 2.53x | 2.28x | — |
The headline numbers were essentially in line, not a clean beat. Underlying diluted EPS of $1.46 was close to the published consensus of roughly $1.47, while net sales of $2.93 billion came in modestly below the roughly $2.94 billion expectation. That makes the formal scorecard broadly in line, but not positive versus the market bar.
The underlying business weakened materially beneath the accounting noise. Consolidated financial volume fell 3.0% and brand volume fell 4.9%, while constant-currency underlying income before taxes declined 17.4%. Pricing and mix added 1.8% to sales, but that was overwhelmed by lower shipments and sharply higher unit costs. The prior-year goodwill impairment makes reported profit comparisons look dramatically better than the continuing business actually performed. 〔0〕 〔1〕
Horizon 2030 is producing savings, but not yet enough to restore operating momentum. MG&A fell 7.7% reported, and nine-month free cash flow improved to $852.0 million from $782.1 million. But COGS per hectoliter rose 8.6%, including roughly $30 million from Midwest Premium pricing, inflation and volume deleverage. Management explicitly says the strategy's benefits are “not yet scaled enough” to offset third-quarter headwinds. 〔2〕
The balance sheet remains workable, but the cushion narrowed. Net debt was $5.39 billion and leverage rose to 2.53x from 2.28x a year earlier, even as the company continued dividends and share repurchases. The cash-generation improvement helps, but weaker EBITDA means the restructuring and portfolio investment plan is operating with less leverage headroom than last year.
The guidance update is an important disclosure, but its magnitude is unclear here. The filing says 2026 guidance was adjusted because of macroeconomic pressure, consumer behavior, logistics costs and persistent U.K. promotions, but the supplied text does not include the revised numerical ranges. That prevents a precise raised-versus-cut judgment; the qualitative message is that near-term pressure is lasting longer than management previously expected. 〔3〕
Bottom line: This was broadly in line on quarterly EPS, but the quality of the result was weak: volume declines and cost inflation more than offset pricing and restructuring benefits. The turnaround is still being funded by cash generation, but this filing does not show that it is yet changing the underlying growth trajectory.
A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.
A buy-side analyst on every ticker — the whole market decoded the second it moves, before it's a headline. Free gives you a taste. Pro takes the cap off and opens the full read on every company.
by Signing in NOW, claim your FREE 14-day Pro trial!